G.E. de Greef

Discontinuation of tyrosine kinase inhibitor therapy in chronic myeloid leukaemia (EURO-SKI): a prespecified interim analysis of a prospective, multicentre, non-randomised, trial

Johan Richter, Joëlle Guilhot, Franz Gruber et al. · The Lancet Oncology · 2018 · 611 citations · Full text

Medicine, Oncology, Pharmacology +11

Complete Remission of t(11;17) Positive Acute Promyelocytic Leukemia Induced by All-trans Retinoic Acid and Granulocyte Colony-Stimulating Factor

Joop H. Jansen, Marleen C. De Ridder, W.M.C. Geertsma et al. · Blood · 1999 · 83 citations · Full text

Medicine, Hematology, Oncology +12

Serum immunoglobulin class and IgG subclasses levels and the occurrence of homogeneous immunoglobulins during the course of ageing in humans

G.E. de Greef, Maarten J. D. van Tol, Jon Berg et al. · Mechanisms of Ageing and Development · 1992 · 37 citations

Life Sciences, Immunology, Clinical Immunology +6

Age-related changes of the antigen-specific antibody formation in vitro and PHA-induced T-cell proliferation in individuals who met the health criteria of the senieur protocol

G.E. de Greef, G.J. Van Staalduinen, Hikke van Doorninck et al. · Mechanisms of Ageing and Development · 1992 · 21 citations

Life Sciences, Geriatric Medicine, Immunology +17

Influence of ageing on antibody formation in vivo after immunisation with the primary T-cell dependent antigen Helix pomatia haemocyanin

G.E. de Greef, Maarten J. D. van Tol, C. G. M. Kallenberg et al. · Mechanisms of Ageing and Development · 1992 · 14 citations

Life Sciences, Immunology, Immunization +8